Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$8,624,771
-$8,678,136 QoQ
Shares Held
55,033
-51.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#188
of 1,603 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $3,483,940,248 across 16 Drug Manufacturers - General names. NVS ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
781,929 | $937,869,169 | |
| 2 | JNJ |
Johnson & Johnson
|
2,675,500 | $679,496,724 | |
| 3 | ABBV |
AbbVie Inc.
|
1,621,115 | $407,937,369 | |
| 4 | AZN |
Astrazeneca PLC
|
2,033,587 | $385,608,756 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,578,024 | $331,276,081 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,215,423 | $242,892,664 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,070,731 | $135,276,147 | |
| 8 | PFE |
Pfizer Inc
|
5,482,863 | $132,027,333 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,624,771 | 55,033 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $17,302,907 | 113,276 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $13,409,097 | 97,259 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $9,310,735 | 72,604 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,770,281 | 22,893 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,900,398 | 17,047 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $979,911 | 10,070 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,084,063 | 9,425 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $678,682 | 6,375 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $434,511 | 4,492 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $352,183 | 3,488 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $260,252 | 2,555 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,165,848 | 31,373 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $4,532,472 | 49,266 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $9,502,919 | 104,750 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,917,960 | 25,233 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $14,366,549 | 169,958 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $7,703,660 | 87,791 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $7,927,843 | 90,635 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $7,266,970 | 88,860 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $8,392,346 | 91,981 | Shares | Defined | 2021-08-04 | |
| 2020-09-30 | $2,286,961 | 26,299 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $2,306,300 | 26,406 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $4,572,924 | 55,463 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||